Pharmacokinetics and Safety/Tolerability of CKD-379

Clinical trial NCT05719155 · COMPLETED

Trial details

NCT number: NCT05719155
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type II Diabetes Mellitus

Start date: 2023-02-27
Primary completion: 2023-03-23
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.